Consensus TransMedics Group, Inc.

Equities

TMDX

US89377M1099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
138 ^USD	+2.26%		+6.15%	+74.81%

May. 08	Transmedics Group Insider Sold Shares Worth $3,902,100, According to a Recent SEC Filing	MT
May. 08	Transmedics Group Insider Sold Shares Worth $759,479, According to a Recent SEC Filing	MT

Evolution of the average Target Price on TransMedics Group, Inc.

Price target over the last 5 years

History of analyst recommendation changes

9ba9f798d0876bea.T7vPoCfrAgjh6mDsTplUN5bf3z7U4ZhaxxWUBbIJMKc.ONm7-VPfRW-A0gbdJM09VM-LmHuwlvs4llDGMeFaVsgKzJvXfd9SSZaeUA~595420e70ba0413f861d08d8558eba89

Analyst Recommendations on TransMedics Group, Inc.

Transmedics Group Insider Sold Shares Worth $3,902,100, According to a Recent SEC Filing	May. 08	MT
Transmedics Group Insider Sold Shares Worth $759,479, According to a Recent SEC Filing	May. 08	MT
Transmedics Group Insider Sold Shares Worth $930,278, According to a Recent SEC Filing	May. 08	MT
Transmedics Group Insider Sold Shares Worth $1,920,000, According to a Recent SEC Filing	May. 08	MT
Transmedics Group Insider Sold Shares Worth $7,986,219, According to a Recent SEC Filing	May. 03	MT
Transmedics Group Insider Sold Shares Worth $1,600,633, According to a Recent SEC Filing	May. 03	MT
Oppenheimer Adjusts TransMedics Group Price Target to $125 From $105, Maintains Outperform Rating	May. 01	MT
Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing	Apr. 18	MT
Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing	Apr. 05	MT
Transmedics Group Insider Sold Shares Worth $1,110,150, According to a Recent SEC Filing	Apr. 02	MT
Piper Sandler Initiates TransMedics Group With Overweight Rating, $95 Price Target	Mar. 28	MT
Oppenheimer Adjusts TransMedics Group Price Target to $105 From $92, Maintains Outperform Rating	Feb. 27	MT
Morgan Stanley Adjusts TransMedics Group Price Target to $75 From $54, Maintains Equal Weight Rating	Dec. 04	MT
Morgan Stanley Adjusts Price Target on TransMedics to $54 From $50, Maintains Equal-Weight Rating	Nov. 07	MT
Waning Optimism on Rate Cuts Pushes Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday	Nov. 07	MT
Earnings, Rates Blunt Wall Street Pre-Bell; Asia Down Europe Flat	Nov. 07	MT
Morgan Stanley Adjusts Price Target on TransMedics Group to $50 From $81, Keeps Equalweight Rating	23-10-13	MT
Morgan Stanley Adjusts Price Target on TransMedics to $50 From $81, Maintains Equal-Weight Rating	23-10-13	MT
Oppenheimer Adjusts TransMedics Group Price Target to $92 From $90, Maintains Outperform Rating	23-08-04	MT
William Blair Initiates TransMedics at Outperform	23-07-19	MT
Canaccord Genuity Adjusts Price Target on TransMedics to $86 From $91, Maintains Buy Rating	23-05-18	MT
Morgan Stanley Adjusts Price Target on TransMedics Group to $81 From $74, Maintains Equalweight Rating	23-05-03	MT
Oppenheimer Adjusts TransMedics Price Target to $90 From $85, Maintains Outperform Rating	23-05-02	MT
JPMorgan Stanley Adjusts TransMedics Group's Price Target to $81 From $67, Keeps Overweight Rating	23-02-23	MT
Morgan Stanley Adjusts TransMedics Group's Price Target to $74 From $63, Keeps Equalweight Rating	23-02-23	MT